Chemokines are a superfamily of small (8–14 kDa) secreted proteins that function as chemoattractant cytokines, directing the migration of leukocytes to sites of inflammation, infection, and tissue injury. They also play critical roles in immune surveillance, lymphoid organ development, angiogenesis, and hematopoiesis. The chemokine superfamily is divided into four subfamilies—CXC, CC, CX3C, and C—based on the arrangement of N-terminal cysteine residues in the mature peptide. More than 50 chemokines and approximately 20 chemokine receptors have been identified in humans, making this system one of the most complex and finely tuned networks of intercellular communication. Historically, recombinant chemokines were produced using animal-derived culture supplements or purification reagents, posing risks of xenogeneic contamination. The emergence of animal-free manufacturing processes has addressed these concerns, providing chemokines that are entirely free of animal-derived materials while retaining full chemotactic and biological activity for advanced applications in immunotherapy, cell therapy, and regenerative medicine.

Definition and Characteristics of Animal-Free Recombinant Chemokines

Animal-free recombinant chemokines are chemotactic cytokines produced through completely animal-component-free manufacturing processes. This designation confirms that no animal- or human-derived materials are used at any stage of expression, purification, or formulation. These proteins are typically recombinant human, mouse, pig, or other species chemokines expressed in systems such as Escherichia coli, plant cells, or human cell lines under chemically defined, animal origin-free conditions. Animal-free chemokines are characterized by high purity (typically ≥95–98% by SDS-PAGE and HPLC), low endotoxin levels (frequently <0.1 EU/µg), and carrier-protein-free formulations. They retain full biological activity comparable to conventionally produced chemokines, as confirmed by functional assays such as chemotaxis of cytokine-activated T-cells, monocytic leukemia THP-1 cells, or BaF3 cells transfected with chemokine receptors.